Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Recruiting now · Phase 2

Conditions studied: High-Risk Non-Muscle-Invasive Bladder Cancer

In brief

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.

Key facts

Study ID

NCT06567743

Run by

CG Oncology, Inc.

People needed

325

Starts

2024-09-16

Expected to finish

2027-12-30

Last updated by the study team

2026-04-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Urologic Specialists of Northwest Indiana (Solaris) — Merrillville, Indiana, United States (enrolling)
• Urology Center of Iowa Research — Clive, Iowa, United States (enrolling)
• Mayo Clinic Arizona — Phoenix, Arizona, United States (enrolling)
• Michael G Oefelein, MD Clinical Trials — Bakersfield, California, United States (enrolling)
• Genesis Research (Greater Los Angeles) — Los Alamitos, California, United States (enrolling)
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States (enrolling)
• Urology Center of Southern California — Murrieta, California, United States (enrolling)
• Arkansas Urology — Little Rock, Arkansas, United States (enrolling)
• Om research — San Diego, California, United States (enrolling)
• University of Southern California — San Diego, California, United States (enrolling)
• Genesis Research (Greater Los Angeles) — Torrance, California, United States (enrolling)
• Colorado Urology — Lakewood, Colorado, United States (enrolling)
• Urology Associates, Lone Tree — Lone Tree, Colorado, United States (enrolling)
• University of Florida — Gainesville, Florida, United States (enrolling)
• Mayo Clinic Florida — Jacksonville, Florida, United States (enrolling)
• Advanced Urology Institute (Solaris) — Largo, Florida, United States (enrolling)
• Advanced Urology Institute — Oxford, Florida, United States (enrolling)
• University of California, Irvine — Orange, California, United States (enrolling)
• Emory University — Atlanta, Georgia, United States (enrolling)
• Associated Urological Specialists — Chicago Ridge, Illinois, United States (enrolling)
• Uropartners — Glenview, Illinois, United States (enrolling)
• Urology of Indiana - Carmel — Carmel, Indiana, United States (enrolling)
• Urology of Indiana, LLC (US Urology Partners) — Greenwood, Indiana, United States (enrolling)
• First Urology, PSC — Jeffersonville, Indiana, United States (enrolling)
• Wichita Urology Group — Wichita, Kansas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.